Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2009
10/29/2009CA2722508A1 Polymeric artificial tear system
10/29/2009CA2722393A1 Liquid formulation for deferiprone with palatable taste
10/29/2009CA2722376A1 Therapeutic use of new pharmaceutical preparations containing antitumoral drugs bound to hyaluronic acid in the treatment of neoplasias
10/29/2009CA2722169A1 Factor ix conjugates with extended half-lives
10/29/2009CA2722112A1 Treating eosinophilic esophagitis
10/29/2009CA2722092A1 Biocompatible crosslinked hydrogels, drug-loaded hydrogels and methods of using the same
10/29/2009CA2721985A1 Thiolated chitosan gel
10/29/2009CA2721983A1 Anti-tnf (alpha) antibody
10/29/2009CA2721938A1 Chitosan-containing protective composition
10/29/2009CA2721927A1 Auris formulations for treating otic diseases and conditions
10/29/2009CA2721657A1 Vaccine compositions for the treatment of dengue fever and uses thereof
10/28/2009EP2112167A2 Humanized ANTI-ERBB2 antibodies and treatment with ANTI-ERBB2 antibodies
10/28/2009EP2112161A2 Peptides that lower blood glucose levels
10/28/2009EP2111876A2 Crosslinked polymer compositions and methods for their use
10/28/2009EP2111872A2 Hydrogel polymeric conjugates of a prodrug
10/28/2009EP2111871A1 Stabilised fluid formula
10/28/2009EP2111837A1 Band seal for hard capsules having peg encapsulated therein
10/28/2009EP2111418A1 Hollow microparticles
10/28/2009EP2111236A2 Novel cascade polymer complexes, method for their production and pharmaceutical agents containing the same
10/28/2009EP2111220A2 Peptides that target to tumor blood vessels of lung cancer and applications thereof
10/28/2009EP2111219A2 Lung cancer-targeted peptides and applications thereof
10/28/2009EP1915129B1 Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation
10/28/2009EP1850830B1 Suppository for binding of reactive oxygen compounds in human and animal bodies
10/28/2009EP1644030B1 Liquid, aqueous pharmaceutical composition of factor vii polypeptides
10/28/2009EP1503800B1 Treatment and prevention of tissue damage associated with increased c-reactive protein production
10/28/2009EP1474120B1 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
10/28/2009EP1430082B1 Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
10/28/2009EP1408967B1 PHARMACEUTICAL COMPOSITIONS BASED ON Tiotropium, Ciclesonide AND a BETAMIMETIC AGENT FOR THE TREATMENT OF INFLAMMATORY AND/OR OBSTRUCTIVE RESPIRATORY TRACT DISEASES
10/28/2009EP1346218B1 Tripeptide of fc gamma riia
10/28/2009EP1181047B2 Composition comprising alkaline sphingomyelinase of bacterial origin for use as a dietetic preparation, food supplement or pharmaceutical product
10/28/2009EP1128731B1 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof
10/28/2009EP0975340B2 Therapeutic inhibitor of vascular smooth muscle cells
10/28/2009CN101568351A Controlled release composition and process
10/28/2009CN101568340A Percutaneous absorption preparation
10/28/2009CN101566615A Bio-sensing and drug slow-release system based on intelligent gel porous silicon composite material
10/28/2009CN101565858A Composition containing peptide binding domain and method for forming nanoparticles and nanowires therefrom
10/28/2009CN101565498A Polyaspartic diol ester containing amino side chain, synthesis method and application thereof
10/28/2009CN101565469A Acid amide-grafted sodium alginate nanometer material, preparation method thereof and use thereof
10/28/2009CN101565465A Surface antigen 1 of Toxoplasma gondii human antibody Fab fragment and encoded gene thereof
10/28/2009CN101565384A Cyclodextrin modified monolayer graphite, supramolecular complex thereof, preparation method and application
10/28/2009CN101564667A Method for preparing alginate soft capsule
10/28/2009CN101564539A Chitosan oligosaccharide fatty acid grafting-adriamycin bonded drug, preparation and applications
10/28/2009CN101564538A 3, 5-dihydroxy-4-isopropyl diphenyl ethylene-butanedioic anhydride-polyoxyethylene compound and synthetic method thereof
10/28/2009CN101564537A 3, 5-dihydroxy-4-isopropyl diphenyl ethylene-ethyl bromoacetate-polyoxyethylene compound and synthetic method thereof
10/28/2009CN101564526A Channel and collateral dredging king
10/28/2009CN101564520A Plastic umbilical plaster for external use, preparation method thereof, plastic infantile diarrhea umbilical plaster and preparation method thereof
10/28/2009CN101564515A Bony spur preparation and preparation method thereof
10/28/2009CN101564501A Big activating collateral preparation and preparation method thereof
10/28/2009CN101564500A Dendrobium noctilucent preparation and preparation method thereof
10/28/2009CN101564481A Bone-setting anti-bruise powder preparation and preparation method thereof
10/28/2009CN101564477A Small activating collateral preparation and preparation method thereof
10/28/2009CN101564471A Preparation method of buccal tablets for treating laryngeal disease
10/28/2009CN101564457A Lizardtail lignan dispersible tablet
10/28/2009CN101564456A Lizardtail lignan drop pill
10/28/2009CN101564442A Preparation of cassia twig and Indian buead and preparation method thereof
10/28/2009CN101564441A Apoplexy rejuvenation preparation and preparation method thereof
10/28/2009CN101564434A Huli powder preparation and preparation method thereof
10/28/2009CN101564415A Chinese medicine microemulsion preparation with enhanced percutaneous permeability and preparation method thereof
10/28/2009CN101564414A Western bovine bezoar preparation and preparation method thereof
10/28/2009CN101564413A Storax preparation of coronary disease and preparation method thereof
10/28/2009CN101564400A Antibacterial supermolecule aquogel and preparation method and application thereof
10/28/2009CN101564383A Skin external used patch
10/28/2009CN101564381A Gemcitabine hydrochloride lyophilized powder injection
10/28/2009CN101564380A Magnetic liposome and method for preparing same
10/28/2009CN101564377A Oxybutynin transdermal gel and the preparation method thereof
10/28/2009CN101564376A Decoquinate solid dispersoid and preparation method thereof
10/28/2009CN101564375A Chinese medicinal in situ forming eye gel
10/28/2009CN101564374A Medicinal in situ forming eye gel
10/28/2009CN100553681C Chloromycetin solution for eye and preparation method thereof
10/28/2009CN100553680C Soft capsule preparation
10/28/2009CN100553679C Chloromycetin solution for eye and preparation method thereof
10/28/2009CN100553678C Novel albumin-free factor VIII formulations
10/28/2009CN100553675C Process of preparing calcitonin microsphere
10/28/2009CN100553674C Medicinal composition of recombinant human parathormone(1-84) and its preparing process
10/28/2009CN100553672C Freeze-dried powder injection for injection for brain refreshment and its preparing method
10/28/2009CN100553654C Ointment for treating burn and scald and preparation method thereof
10/28/2009CN100553649C A composition for regulating intestinal canal flora and improving hypoxia tolerance as well as its preparation method
10/28/2009CN100553646C Use of probiotic lactic acid bacteria for balancing the skin's immune system
10/28/2009CN100553645C Solid pipefish dispersion and its preparation method and application
10/28/2009CN100553630C Controlled release formulation for oral administration of metformin
10/28/2009CN100553625C Oral suspension of active principle microcapsules
10/28/2009CN100553622C An enteric coated mini-pill of pantoprazole sodium
10/28/2009CN100553621C Multi-component pharmaceutical dosage form
10/28/2009CN100553614C Preparation method of quickly disintegrating and dissolving solid medicine composition for oral cavity and its tablet
10/28/2009CN100553612C Preparing process of nano c-FLIP antisense oligonucleotide particle
10/28/2009CN100553500C A process for the preparation of antioxidant preservative from Indian curry leaves
10/27/2009US7608694 Neutralizing antibody with specificity for antigenic determinants; infections (viral, bacterial, fungal and parasitic), endotoxic shock associtated with infection, arthritis, rheumatoid arthritis, pelvic inflammatory disease, Alzheimer's Disease, Crohn's disease
10/27/2009US7608692 or exendin-4 agonists covalently bonded to albumin, polyethylene glycol, gelatin, (hydroxypropyl)-methacrylamide, a polyamino acid, fatty acid, polysaccharide, dextran to increase molecular size; diabetes, postprandial dumping syndrome, postprandial hyperglycemia, dyslipidemia, obesity; renal filtration
10/27/2009US7608687 Releasable linkage and compositions containing same
10/27/2009US7608681 Methods and compositions for prolonging elimination half-times of bioactive compounds
10/27/2009US7608610 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism
10/27/2009US7608609 Pharmaceutical composition
10/27/2009US7608608 Pharmaceutical composition
10/27/2009US7608607 Pharmaceutical composition
10/27/2009US7608606 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism
10/27/2009US7608605 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism
10/27/2009US7608591 Targeted delivery to legumain-expressing cells
10/27/2009US7608582 Channel protein modified with a pH-responsive or light-responsive compound, coupling group C in combination with either a chargeable group or with a photocleavable chargeable group
10/27/2009US7608580 Osteogenic protein such as Bone Morphogenic Protein, hyaluronic acid derivatives and porogen or sodium bicarbonate; bone repair, or tendon, cartilage repair; allows for closed fracture repair
10/27/2009US7608278 Less painful immunogenic composition of a hydrophobic protein; solubilizing hydrophobic protein with a zwitterionic detergent to make a composition that is then altered; meningitis or gonorrhea
1 ... 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 ... 1712